生物界面工程通过融合基因技术和特定站点生长因子结合来实现高效的骨质分化
Zhenxu Wu1, Li Mo1,2, Zongliang Wang1
1Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, People's Republic of China.
Biotechnology and bioengineering
|September 20, 2024
概括
这项研究通过将生长因子固定在PLGA/HA基板上来设计骨植入物. 这种仿生方法显著增强了骨细胞分化,用于骨科和牙科应用.
科学领域:
- 生物材料工程 生物材料工程
- 组织工程是组织工程.
- 表面化学 表面化学
背景情况:
- 骨植入物发育需要有效的生物接口来增强骨分化.
- 生物灵感增长因子的固定化对于产生这些接口至关重要.
- 目前提供增长因素的方法可能缺乏具体性和效率.
研究的目的:
- 开发一种简单的,特定于特定地点的策略,以使多乳酸糖化物 (PLGA) 和酸 (HA) 复合基底与骨形态遗传蛋白2 (BMP2) 功能化.
- 使用工程仿生材料增强细胞的骨质分化.
- 为骨科和牙科应用提出微生物辅助工程方法.
主要方法:
- 使用修改BMP2 (DOPA-BMP2) 的特定位点对合的PLGA/HA基质的表面功能化.
- 在大肠杆菌中BMP2-LPETG的重组表达.
- 使用氨酸酶和随后由类酶A (SrtA) 介导的结合,对氨酸残留物进行DOPA的酶性修饰.
主要成果:
- 成功表达和修改BMP2以提高结合亲和力 (DOPA-BMP2).
- 通过SrtA结合,实现了DOPA-BMP2与PLGA/HA基质的特定位点结合.
- 设计的DOPA-BMP2/PLGA/HA基质显著促进了MC3T3-E1细胞的骨质分化.
结论:
- 使用微生物辅助方法开发了一种简单且高度特定于地点的生物模拟材料工程策略.
- 在骨科和牙科应用中,DOPA-BMP2/PLGA/HA复合基板显示出增强骨再生的巨大潜力.
- 这种方法提供了一个多功能平台,可以为生物材料提供生长因子和其他生物宏分子.
更多相关视频
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
11.6K
09:34Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
Published on: September 7, 2017
9.3K
相关概念视频
01:28Forced Transdifferentiation
1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
1.9K
00:59Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
01:59Plant Breeding and Biotechnology
18.8K
Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.
18.8K